CORBUS PHARMACEUTICALS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 25 Mar 2023)
What this means for you
Registered since 27 Sept 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal was due 27 Sept 2026; it can still be filed, with a surcharge, until 27 Mar 2027).
Record
- Serial number
- 86979984
- Registration number
- 5051442
- Mark type
- Word mark
- Filed
- 12 Aug 2015
- Published for opposition
- 29 Mar 2016
- Registered
- 27 Sept 2016
- Next maintenance filing
- §8 & §9 renewal, due by 27 Sept 2026 (grace period to 27 Mar 2027)
- Attorney of record
- Jeffrey J. Ellison
Goods and services
- Class 044 — Medical, beauty and agricultural services: Providing personalized healthcare and medical information in the area of fibrosis and inflammation
Owner
- Corbus Pharmaceuticals, Inc., Norwood, MA, US
- Corbus Pharmaceuticals, Inc., Norwood, MA, US
- Corbus Pharmaceuticals, Inc., Newton, MA, US
Prosecution history
- 27 Sept 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 25 Mar 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 25 Mar 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 25 Mar 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Sept 2022 — TEAS SECTION 8 & 15 RECEIVED
- 27 Sept 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 21 Aug 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Aug 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Nov 2016 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Nov 2016 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Sept 2016 — REGISTERED-PRINCIPAL REGISTER
- 20 Aug 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Aug 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Aug 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Jul 2016 — USE AMENDMENT FILED